Strategic Financial Services’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Hold
37,000
0.02% 118
2026
Q1
$234K Hold
37,000
0.01% 137
2025
Q4
$231K Hold
37,000
0.01% 133
2025
Q3
$239K Buy
37,000
+6,000
+19% +$37.9K 0.01% 126
2025
Q2
$216K Hold
31,000
0.01% 132
2025
Q1
$148K Hold
31,000
0.01% 133
2024
Q4
$160K Hold
31,000
0.01% 136
2024
Q3
$113K Hold
31,000
0.01% 141
2024
Q2
$150K Hold
31,000
0.01% 131
2024
Q1
$164K Hold
31,000
0.01% 126
2023
Q4
$157K Hold
31,000
0.01% 127
2023
Q3
$160K Hold
31,000
0.01% 120
2023
Q2
$156K Hold
31,000
0.01% 122
2023
Q1
$160K Hold
31,000
0.01% 119
2022
Q4
$190K Hold
31,000
0.02% 121
2022
Q3
$232K Hold
31,000
0.02% 121
2022
Q2
$269K Hold
31,000
0.02% 115
2022
Q1
$299K Buy
31,000
+972
+3% +$8.39K 0.02% 112
2021
Q4
$240K Hold
30,028
0.02% 123
2021
Q3
$277K Hold
30,028
0.02% 113
2021
Q2
$285K Hold
30,028
0.02% 120
2021
Q1
$289K Hold
30,028
0.02% 119
2020
Q4
$179K Hold
30,028
0.02% 132
2020
Q3
$163K Hold
30,028
0.02% 122
2020
Q2
$141K Hold
30,028
0.02% 123
2020
Q1
$114K Buy
30,028
+2,000
+7% +$9.85K 0.02% 118
2019
Q4
$144K Buy
+28,028
New +$145K 0.02% 131

Other funds holding ICCC

Strategic Financial Services's ICCC Position: Q2 2026 in Review

Strategic Financial Services held its ImmuCell (ICCC) position steady in Q2 2026 at 37,000 shares worth $372K. The position accounts for 0.02% of the portfolio, ranked #118.

Strategic Financial Services first reported a position in ICCC in Q4 2019 and has held it in 27 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Strategic Financial Services held 37,000 shares of ImmuCell worth $372K as of Q2 2026.
  • Strategic Financial Services left its ImmuCell share count unchanged in Q2 2026.
  • ImmuCell made up 0.02% of Strategic Financial Services's portfolio in Q2 2026, its #118 holding.
  • Strategic Financial Services first reported a position in ImmuCell in Q4 2019 and has held it in 27 quarters since.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Strategic Financial Services's 13F filing for Q2 2026, filed 24 Aug 2026.